OKUR
OnKure Therapeutics, Inc. · Healthcare · Market cap $93.1M
Insiders sold $1K net in the last 90 days ·2 sellers, 0 buyers· latest Form 4 filed Sep 23, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$6K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Latest filing
Sep 23, 2026
Saccomano Nicholas A
OnKure Therapeutics, Inc. (OKUR) has 10 SEC Form 4 filings (10 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Sep 23, 2026.
Inside the rolling window, 2 insiders at OnKure Therapeutics, Inc. reported no open-market purchases and 8 open-market sales totaling $6K. The most active filer is President and CEO Saccomano Nicholas A with 4 filings. The most recent open-market filing is a sale of 87 shares by President and CEO Saccomano Nicholas A, dated Sep 21, 2026, worth $259.
- Industry:Biotechnology
- CEO:Nicholas A. Saccomano
- Employees:45
- HQ:Boulder, CO, US
- IPO:2021-04-08
| Source | |||||||
|---|---|---|---|---|---|---|---|
Saccomano Nicholas AFirst in 3 months | President and CEO | Sale | 87 | $259 | Sep 23 | -21.8% | SEC ↗ |
Leverone Jason A.First in 3 months | Chief Financial Officer | Sale | 302 | $898 | Sep 23 | -21.8% | SEC ↗ |
Saccomano Nicholas AFirst in 3 months | President and CEO | Sale | 86 | $378 | Jun 24 | -47.0% | SEC ↗ |
Leverone Jason A.First in 3 months | Chief Financial Officer | Sale | 303 | $1K | Jun 24 | -47.0% | SEC ↗ |
Saccomano Nicholas AFirst in 3 months | President and CEO | Sale | 86 | $357 | Mar 24 | -42.2% | SEC ↗ |
Leverone Jason A.First in 3 months | Chief Financial Officer | Sale | 301 | $1K | Mar 24 | -42.2% | SEC ↗ |
Saccomano Nicholas AFirst filing | President and CEO | Sale | 87 | $258 | Dec 23 | -18.7% | SEC ↗ |
Leverone Jason A.First filing | Chief Financial Officer | Sale | 302 | $896 | Dec 23 | -18.7% | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does OKUR have?
OnKure Therapeutics, Inc. (OKUR) has 10 SEC Form 4 filings (10 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Sep 23, 2026.
When was the most recent SEC Form 4 filing for OKUR?
The most recent Form 4 filing for OKUR on Tracefour is dated Sep 23, 2026.
Who is the most active insider at OKUR?
The most active SEC Form 4 filer at OKUR in the rolling window is President and CEO Saccomano Nicholas A, with 4 filings.
What is the net insider flow at OKUR over the last 6 months?
Over the trailing 180 days, insiders at OKUR have net sold $3K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at OKUR in the current window?
Inside the rolling window, insiders at OKUR bought $0 and sold $6K based on SEC Form 4 filings.
Can I get alerts for OKUR insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at OnKure Therapeutics, Inc. (OKUR). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
OnKure Therapeutics, Inc. is in the Healthcare sector.